📷 Image Credits: Mint
The initial public offering (IPO) of Kronox Lab Sciences Limited has opened today, with a public issue worth ₹130.15 crore. The IPO will remain open for bidders until June 5th, 2024. The book build issue is complete, offering for sale (OFS), which means the IPO won’t have any immediate impact on the company’s balance sheet. The company has set the Kronox Lab Sciences IPO price band at ₹129 to ₹136 per equity share. Market observers have noted that shares of Kronox Lab Sciences are available at a premium of ₹83 in the grey market today.
The book build issue got fully subscribed within half an hour of opening, with the public issue being booked 3.84 times by 12:15 PM on day one. The retail portion was booked 5.59 times, and the NII segment subscribed 4.88 times.
Key details of the Kronox Lab Sciences IPO include the pricing, subscription status, allotment date, registrar information, listing plans, and subscription review. The company specializes in manufacturing High Purity Specialty Fine Chemicals used in various industries globally.
As highlighted by Axis Capital, the company has shown significant growth in revenues, EBITDA, and PAT between Fiscal 2021 and 2023. Swastika Investmart has given the IPO a ‘buy’ tag, indicating positive outlook.
Investors are advised to consider the company’s financials and recommendations from experts before making any investment decision. For more insights into the IPO, potential investors can refer to the detailed information provided. Stay updated with the latest market news and IPO trends by following Live Mint for continuous coverage and analysis.
